Importantly, muscle cells appear to be less sensitive than breast cancer cells to DOX-mediated cytotoxicity when administered in conjunction with magnetic exposure (Figure 5), possibly reflecting inherently lower expression levels of TRPC1 in healthy muscle. The gene discussed is TRPC1; the disease is breast cancer.